Understanding these differences affects your body, results, and safety when choosing between options
A limited number of studies extended their inclusion to non-diabetic obese populations (e.g., the adolescent obesity trial by Kelly 2020 and the obesity intervention trial by Tronieri 2019)
Higher doses (10 mg and 15 mg) showed increased frequency of digestive symptoms compared to lower doses
Take Control of Your Weight Loss Journey If you are experiencing fatigue or other side effects while on your weight loss journey, having a clinical team that prioritizes dose optimization and supportive care is essential
The company also publishes educational content on proper reconstitution, storage, and injection technique, helping both new prescribers and patients navigate peptide therapy safely
Among episodes of GLP-1-receptor agonist use, mean (SD) age was 59.7 (10.8) years and 43.5% were female